Sabby Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-11,500
| Closed | -$1.37M | – | 89 |
|
|
2018
Q1 | $1.37M | Sell |
11,500
-7,750
| -40% | -$923K | 0.16% | 17 |
|
|
2017
Q4 | $2.45M | Buy |
+19,250
| New | +$2.45M | 0.22% | 8 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 84 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 115 |
|
|
2017
Q1 | – | Sell |
-13,823
| Closed | -$518K | – | 130 |
|
|
2016
Q4 | $518K | Buy |
+13,823
| New | +$518K | 0.03% | 88 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 154 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 154 |
|
|
2015
Q4 | – | Sell |
-6,809
| Closed | -$547K | – | 156 |
|
|
2015
Q3 | $547K | Buy |
+6,809
| New | +$547K | 0.02% | 142 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 144 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 129 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 109 |
|
|
2014
Q3 | – | Sell |
-12,000
| Closed | -$758K | – | 113 |
|
|
2014
Q2 | $758K | Buy |
+12,000
| New | +$758K | 0.03% | 71 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 62 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 48 |
|